The Devyser blog

News | July 19, 2018

Recent Research in Predicting Onset of AML – Oncology

Two new studies attempting to define the genetic landscape of individuals who later develop Acute Myeloid Leukemia (AML) were recently published in Nature and Nature Medicine

Find out more

Filter

All articles

New Whitepaper: Familial Hypercholesterolemia

Devyser is pleased to announce the publication of a new whitepaper Familial Hypercholesterolemia:...

Devyser and Dahui Biotech sign distribution deal for the Chinese market

Devyser, pioneer in diagnostic kits for complex DNA testing, and Dahui Biotech, major supplier of...

Devyser opens subsidiary in Germany

Devyser announces the opening of Devyser GmbH near Frankfurt, Germany, to strengthen its local...

JSI develops customized software plug-in for Devyser’s new NGS products

Devyser and JSI medical systems announce a joint solution for in-house processing of...

Devyser and Sophia Genetics partner to simplify routine diagnostics

Devyser, pioneer in diagnostic kits for complex DNA testing and Sophia Genetics, global leader in...

Genomeweb covers Devyser’s latest developments

Genomeweb covers Devyser’s latest developments.

New board members appointed

Devyser Holding AB announced at its annual general meeting yesterday the appointment of two new...

Devyser raises 15 msek in funding

Devyser has raised 15msek ($1,8m) in funding to support the launch of new cancer diagnostic...

< 2 3 4 5 6